Mothes E, Shoeman R L, Traub P
Max-Planck-Institut für Zellbiologie, Ladenburg, Germany.
Micron. 1994;25(2):189-217. doi: 10.1016/0968-4328(94)90042-6.
Pepstatin A, a pentapeptide with the molecular weight of 686, is a naturally occurring inhibitor of aspartyl proteases secreted by Streptomyces species. Above a critical concentration of 0.1 mM at low ionic strength and neutral pH, it can polymerize into filaments which may extend over several micrometers. After negative staining, these filaments show a helical substructure with characteristic diameters ranging from 6 to 12 nm. Selected images at higher magnification suggest the filaments are composed of two intertwined 6 nm strands. This is in agreement with the optical diffraction analysis which additionally established a periodic pitch of 25 nm for the helical intertwining. Rotary shadowing of the pepstatin A filaments clearly demonstrated the right-handedness of the helical twist. In physiological salt solution or at higher concentrations of pepstatin A, a variety of higher order structures were observed, including ribbons, sheets and cylinders with both regular and twisted or irregular geometries. Pepstatin A can interact with intermediate filament subunit proteins. These proteins possess a long, alpha-helical rod domain that forms coiled-coil dimers, which through both hydrophobic and ionic interactions form tetramers which, in turn, in the presence of physiological salt concentrations, polymerize into the 10 nm intermediate filaments. In the absence of salt, pepstatin A and intermediate filament proteins polymerize into long filaments with a rough surface and a diameter of 15-17 nm. This polymerization appears to be primarily driven by nonionic interactions between pepstatin A and polymerization-competent forms of intermediate filament proteins, resulting in a composite filament. Polymerization-incompetent proteolytic fragments of vimentin, lacking portions of the head and/or tail domain, failed to copolymerize with pepstatin A into long filaments under these conditions. These peptides, as well as bovine serum albumin, were found to stick to the surface of pepstatin A filaments, ribbons and sheets. Independent evidence for direct association of pepstatin A with intermediate filament subunit proteins was provided not only by electron microscopy but also by UV difference spectra. Pepstatin A loses its ability to inhibit the aspartyl protease of the human immunodeficiency virus type 1 following polymerization into the higher order structures described here. The amazing fact that pepstatin A can spontaneously self-associate to form very large polymers seems to be a more rare event for such small peptides. The other examples of synthetic or naturally occurring oligopeptides discussed in this review which are able to polymerize into higher order structures possess a common property, their hydrophobicity, often manifested by clusters of valine or isoleucine residues.(ABSTRACT TRUNCATED AT 400 WORDS)
胃蛋白酶抑制剂A是一种分子量为686的五肽,是链霉菌属分泌的天冬氨酸蛋白酶的天然抑制剂。在低离子强度和中性pH值条件下,当浓度高于临界值0.1 mM时,它可聚合成长达数微米的细丝。负染后,这些细丝呈现出螺旋亚结构,特征直径在6至12纳米之间。高倍放大下的选定图像表明,细丝由两条相互缠绕的6纳米链组成。这与光学衍射分析结果一致,该分析还确定了螺旋缠绕的周期间距为25纳米。胃蛋白酶抑制剂A细丝的旋转阴影清楚地表明了螺旋扭曲的右手性。在生理盐溶液中或胃蛋白酶抑制剂A浓度较高时,观察到多种高阶结构,包括具有规则、扭曲或不规则几何形状的带、片和圆柱体。胃蛋白酶抑制剂A可与中间丝亚基蛋白相互作用。这些蛋白具有一个长的α螺旋杆状结构域,可形成卷曲螺旋二聚体,通过疏水和离子相互作用形成四聚体,进而在生理盐浓度存在的情况下聚合成10纳米的中间丝。在无盐条件下,胃蛋白酶抑制剂A和中间丝蛋白聚合成表面粗糙、直径为15 - 17纳米的长丝。这种聚合似乎主要由胃蛋白酶抑制剂A与具有聚合能力的中间丝蛋白形式之间的非离子相互作用驱动,形成复合丝。波形蛋白的无聚合能力的蛋白水解片段,缺乏头部和/或尾部结构域的部分,在这些条件下不能与胃蛋白酶抑制剂A共聚成长丝。这些肽以及牛血清白蛋白被发现附着在胃蛋白酶抑制剂A的细丝、带和片的表面。不仅通过电子显微镜,而且通过紫外差光谱,都提供了胃蛋白酶抑制剂A与中间丝亚基蛋白直接结合的独立证据。胃蛋白酶抑制剂A聚合成此处所述的高阶结构后,失去了抑制人类免疫缺陷病毒1型天冬氨酸蛋白酶的能力。胃蛋白酶抑制剂A能自发自聚形成非常大的聚合物,这一惊人事实对于如此小的肽来说似乎是更罕见的事件。本综述中讨论的其他能够聚合成高阶结构的合成或天然寡肽实例都具有一个共同特性,即它们的疏水性,通常由缬氨酸或异亮氨酸残基簇表现出来。(摘要截选至400字)